(Q54380064)

29 May 2018

title

Prevention of exercise-induced asthma by indoramin. (English)

1 reference

29 May 2018

0 references

Bianco S

1

1 reference

29 May 2018

Griffin JP

series ordinal

2

1 reference

29 May 2018

Kamburoff PL

series ordinal

3

1 reference

29 May 2018

Prime FJ

series ordinal

4

1 reference

29 May 2018

language of work or name

English

0 references

publication date

1 October 1974

1 reference

29 May 2018

published in

The BMJ

1 reference

29 May 2018

volume

4

1 reference

29 May 2018

issue

5935

1 reference

29 May 2018

page(s)

18-20

1 reference

29 May 2018

Competitive blockade of adrenergic alpha-receptors and histamine receptors by thymoxamine

cites work

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612123

Clinical evaluation of indoramin, a new antihypertensive agent

4 June 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1612123

Pharmacologic studies of indoramin in man

4 June 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/4154121

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Changes in plasma concentration of epinephrine and norepinephrine with muscular work

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/4154121

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1136/BMJ.4.5935.18

1 reference

29 May 2018

PMCID

1612123

1 reference

29 May 2018

PubMed ID

4154121

1 reference

29 May 2018